MMJ BioPharma’s noble pursuit of scientific advancement has been met with a series of inexplicable roadblocks and bureaucratic hurdles erected by the DEA. In 2018, the company dutifully applied for the necessary licenses to cultivate marijuana for research and development purposes, eagerly anticipating the opportunity to commence clinical trials that could yield life-changing treatments. Yet, despite meticulously following the DEA’s convoluted application process, MMJ BioPharma found itself trapped in a seemingly endless cycle of delays, obfuscation, and stonewalling.
Jowell & Randy member Randy is expanding into cannabis with La Zaza, a brand built…
wo of the most popular autoflowering takes on the Cookies family are Auto Girl Scout…
Jamaica has introduced two new special permits designed to help traditional growers and small farmers…
Italy has extensive opioid use, established illicit drug markets and criminal organizations capable of moving…
A strange prophecy sends an isolated artist on a three-day collision with grief, love, creativity,…
Yasquasia Delcarmen was remanded into custody the day her federal sentence came down. Her son…